Gadobenate Dimeglumine Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 529 mg/mL
Reference Brands: MultiHance (USA)
Category:
Contrast Agent
Gadobenate Dimeglumine is available in Injection
and strengths such as 529 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Gadobenate Dimeglumine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Gadobenate Dimeglumine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Gadobenate dimeglumine is a gadolinium-based paramagnetic contrast agent widely used in magnetic resonance imaging (MRI) to enhance the visibility of tissues, organs, and vascular structures. When introduced into a magnetic field, gadobenate dimeglumine generates a strong local magnetic moment, which increases the relaxation rate of nearby protons. This effect improves the signal intensity of tissue images, allowing for clearer and more detailed visualization during MRI scans.
One of the unique features of gadobenate dimeglumine is its preferential uptake by normal, functioning hepatocytes. This selective uptake results in enhanced imaging of healthy liver tissue, while tumor or abnormal tissue remains relatively unenhanced, aiding in the detection and characterization of hepatic lesions. Additionally, because gadobenate dimeglumine is partially excreted through the bile, it can be used to visualize the biliary system, providing valuable information about biliary anatomy and potential obstructions.
Gadobenate dimeglumine is administered intravenously under professional supervision, with careful monitoring to ensure patient safety. Its high relaxivity, dual extracellular and hepatobiliary properties, and favorable safety profile make it a preferred contrast agent in both general and specialized MRI applications, including liver imaging, vascular studies, and tumor detection.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing